Below are the most recent publications written about "Arthritis, Rheumatoid" by people in Profiles.
-
Deane KD, Striebich CC, Feser ML, O'Dell JR, James JA, Sparks JA, Davis JM, Graf J, McMahon MA, Solow EB, Forbess LJ, Tiliakos A, Schiopu E, Danila MI, Horowitz DL, Kay J, Strickland CD, Guthridge JM, Arriens C, Grossman JM, Kristen Demoruelle M, Bemis EA, Frazer-Abel A, Fleischer CL, Fox DA, Mikuls TR, Greenleaf M, York K, Walker S, Keyes-Elstein L, Byron M, Fedler J, Goldmuntz EA, Holers VM. A Phase 2 Trial of Hydroxychloroquine in Individuals at Risk for Rheumatoid Arthritis. Arthritis Rheumatol. 2026 Apr; 78(4):809-820.
-
Jeon KH, Jung J, Cho MH, Lee D, Han K, Cho IY, Shin DW. RA and risk of colorectal cancer: a nationwide cohort study. Rheumatology (Oxford). 2026 01 08; 65(1).
-
Yang B, Han K, Jung JH, Jung W, Kim BG, Eun Y, Kim H, Shin DW, Lee H. Rheumatoid arthritis and risk of non-tuberculous mycobacterial pulmonary disease: a nationwide longitudinal cohort study. BMJ Open Respir Res. 2025 Nov 27; 12(1).
-
Paudel ML, Shadick N, Weinblatt M, Reed G, Litman HJ, Kremer JM, Pappas DA, Solomon DH. Development and External Validation of a Multivariable Predictive Model for Progression to Difficult-to-Treat Rheumatoid Arthritis in Biologic-Experienced Patients. Arthritis Care Res (Hoboken). 2026 Jan; 78(1):54-65.
-
Moon SM, Han K, Jung JH, Park J, Yang B, Eun Y, Choi H, Kim H, Shin DW, Lee H. Risk of pneumonia in individuals with rheumatoid arthritis: a nationwide cohort study. BMJ Open Respir Res. 2025 Sep 25; 12(1).
-
Yang YS, Kim MJ, Chaugule S, Mayer E, DeSouza N, Ma H, Xie J, Lee KY, Li S, Gravallese E, Gao G, Shim JH. Nature-inspired IL-1 targeted therapy to treat chronic inflammatory diseases. Mol Ther. 2025 Dec 03; 33(12):6379-6397.
-
Cho MH, Jung J, Kim TH, Han K, Lee D, Jeon KH, Cho IY, Shin DW. Rheumatoid Arthritis and Risk of Thyroid Cancer: A Nationwide Cohort Study. Arthritis Care Res (Hoboken). 2025 Nov; 77(11):1359-1367.
-
Choi H, Han K, Jung JH, De Soyza A, Kim H, Shin DW, Lee H. Impact of rheumatoid arthritis, seropositivity and disease-modifying anti-rheumatic drugs on mortality risk in bronchiectasis. Ther Adv Respir Dis. 2025 Jan-Dec; 19:17534666251360071.
-
Litman HJ, Sheffield KM, Pugach O, Shan M, Lakin P, Cui ZL, Curtis SE, Johnston JA, Harrold LR. Applying Bias Correction Methods to Build Hybrid Controls Using Real-World Patients for a Phase IIb Randomized Controlled Trial of Baricitinib for Rheumatoid Arthritis. Pharm Stat. 2025 Jul-Aug; 24(4):e70020.
-
Lee D, Jeon KH, Jung J, Han K, Cho MH, Cho IY, Shin DW. Urological cancer risk in patients with rheumatoid arthritis compared to matched controls: a nationwide cohort study. Rheumatology (Oxford). 2025 Jun 01; 64(6):3458-3467.